Effect of an implanted Cytosar-Silicone complex on Ehrlich Ascites Carcinoma.
D000818:Animals; D001202:Ascitic Fluid / Q000032:analysis / Q000166:cytology; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy*; D002452:Cell Count; D003561:Cytarabine / Q000008:administration & dosage* / Q000032:analysis / Q000627:therapeutic use; D003692:Delayed-Action Preparations; D005069:Evaluation Studies as Topic; D005260:Female; D006400:Hematocrit; D007279:Injections, Subcutaneous; D007962:Leukocytes; D008722:Methods; D051379:Mice; D008854:Microscopy, Electron; D010529:Peritoneal Cavity; D012828:Silicones / Q000032:analysis; D013194:Staining and Labeling; D013997:Time Factors
D003692:Delayed-Action Preparations; D012828:Silicones; D003561:Cytarabine